## **Core Concept**
The question pertains to the teratogenic effects of lithium carbonate, a medication commonly used to treat bipolar disorder. Lithium exposure during pregnancy has been associated with an increased risk of cardiac malformations in the fetus. The underlying principle involves the drug's ability to cross the placental barrier and affect fetal development.

## **Why the Correct Answer is Right**
Lithium carbonate is known to increase the risk of **Ebstein's anomaly**, a congenital heart defect characterized by the abnormal formation of the tricuspid valve and the right ventricle. This condition is a specific type of cardiac malformation that has been epidemiologically linked to lithium exposure in utero. The mechanism is not entirely clear but may involve lithium's effects on cardiac cell development and signaling pathways.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While cardiac anomalies are a concern, there are many types, and Ebstein's anomaly is specifically highlighted in the literature as the most concerning and specifically associated with lithium use.
- **Option B:** This option does not specify a known congenital anomaly directly associated with lithium use.
- **Option C:** Similarly, this option lacks specificity regarding a congenital anomaly linked to lithium exposure.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while the risk of cardiac malformations, specifically Ebstein's anomaly, is increased with lithium exposure, the absolute risk remains low. The overall risk of major congenital malformations with lithium use is estimated to be around 2-3%, compared to 1-2% in the general population. However, the concern about Ebstein's anomaly, although rare, is significant enough to warrant careful consideration and monitoring during pregnancy.

## **Correct Answer:** . Ebstein's anomaly